year 15, Issue 4 (July - August 2021)                   Iran J Med Microbiol 2021, 15(4): 392-399 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asgari A, Ataee R, Tavana A M, Mirnejad R, Ghorbanalizdgan M. Real-time RT PCR Evaluation of the Xylitol Effect on the Expression of Streptococcus pneumoniae cpsB,cpsD and psaA Genes. Iran J Med Microbiol 2021; 15 (4) :392-399
URL: http://ijmm.ir/article-1-1302-en.html
1- MS.c of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Professor of Department of Medical Microbiology, Faculty of Medicine, and Applied Microbiology Research Center, System Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran , ataee216@gmail.com
3- Professor of Medical Microbiology, Faculty of Medicine and Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
4- Professor of Medical Microbiology, Applied Microbiology Research Center, System Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
5- Assistant professor of Medical Microbiology, Faculty of Medicine, and Applied Microbiology Research Center, System Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
Abstract:   (2731 Views)

Background and Objective: The major pneumococcal pathogenesis factor is the capsular polysaccharide. the production of polysaccharide is regulated by cpsB and cpsD genes. Thus, every agent that induce or inhibition of expression of these genes probably increased pathogenesis of bacteria, intracellular survival and vis versa. The aim of this study was to assay the effect of Xylitol on Streptococcus pneumoniae cpsB, cpsD, psaA and aroE genes expression by Real Time RT-PCR.
Materials and Methods: During 2019 in Baqiyatallah university laboratories, 20 clinical isolates and a reference strain Streptococcus pneumoniae (ATCC 6305) were studied. To assay the effect of Xylitol and fructose، different concentration of these sugars were exposed to BHI Broth media. Thereafter, the bacterial suspension was added to 5% Xylitol, 5%Xylitol + 5% fructose and control medium for 3hours. RNA was extracted and cDNA synthesis was carried out. Then, the cpsB, cpsD and psaA genes expression levels were measured.
Results: The mean of cpsB gene expression ratio in presence of the % 5 Xylitol treated media compared with those in the control media and % 5 Xylitol + 5% fructose were 0.022 and 0.027 respectively. The means of the cpsD and psaA genes expression ratio in the % 5 Xylitol treated media compared with those in the control media and % 5 Xylitol + 5% fructose were 1.659 and 0.056, and 0.633 and 3.294 respectively.
Conclusion: Our finding revealed that, the 5% Xylitol inhibit the cpsB gene expression properly. Therefore, it is possible to use of Xylitol for reductive on cpsB gene expression and superficial pneumococcal infections control.

Full-Text [PDF 743 kb]   (806 Downloads) |   |   Full-Text (HTML)  (920 Views)  
Type of Study: Original Research Article | Subject: Molecular Microbiology
Received: 2021/03/14 | Accepted: 2021/07/15 | ePublished: 2021/08/16

References
1. Loughran AJ, Orihuela CJ, Tuomanen EI. Streptococcus pneumoniae: Invasion and Inflammation. Microbiol Spectr. 2019 Mar;7(2): 10.1128/microbiolspec.GPP3-0004-2018. [DOI:10.1128/9781683670131.ch20]
2. Luck JN, Tettelin H, Orihuela CJ. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front Cell Infect Microbiol. 2020 Dec 23; 10:613287. [DOI:10.3389/fcimb.2020.613287]
3. Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH. Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev. 2015 Jul;28(3):871-99. [DOI:10.1128/CMR.00024-15]
4. Ataee RA, Habibian S, Mehrabi-Tavana A, Ahmadi Z, Jonaidi N, Salesi M. Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in Iran. Annals of clinical microbiology and antimicrobials. 2014; 13:53. [DOI:10.1186/s12941-014-0053-1]
5. Ataee RA, Hossaini SMJ, Karami A, Safiri Z, Allahverdi M. Simultaneous detection of common bacterial meningitis: Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumonia by multiplex PCR. Trauma Monthly. 2009;14(3):119-26.
6. Ataee RA, Mehrabi Tavana A, Karami A, Izadi M, Hasani SMJ, Safiri Z, et al. The assessment of universal primer for rapid detection of bacterial meningitis. Hakim Res J. 2009;11(4):27-32.
7. Hamaguchi S, Zafar MA, Cammer M, Weiser JN. Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation. Infect Immun. 2018 Feb 20;86(3): e00802-17. [DOI:10.1128/IAI.00802-17]
8. Paton JC, Trappetti C. Streptococcus pneumoniae Capsular Polysaccharide. Microbiol Spectr. 2019 Mar;7(2). [DOI:10.1128/microbiolspec.GPP3-0019-2018]
9. Denapaite D, Hakenbeck R. A New Variant of the Capsule 3 Cluster Occurs in Streptococcus pneumoniae from Deceased Wild Chimpanzees. PLoS ONE. 2011;6(9):25119. [DOI:10.1371/journal.pone.0025119]
10. Habibian S, Mehrabi-T A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype Distribution and Antibiotics Susceptibility Pattern of Streptococcus pneumonia in Iran. Iran. Red Crescent Med J. 2013;15(10):8053. [DOI:10.5812/ircmj.8053]
11. Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, et al. Bergey's Manual of Systematic Bacteriology. 2nd ed. New York: 2009.704.
12. Hyams C, Trzcinski K, Camberlein E, M.Weinberger D,Chimalapati S,Noursadeghi M, et al. Streptococcus pneumoniae Capsular Serotype Invasiveness Correlates with the Degree of Factor H Binding and Opsonization with C3b/iC3b. Infect Immun. 2012;81(1):354. [DOI:10.1128/IAI.00862-12]
13. Obaro S, Adegbola R. The Pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 2002;51(2):98-104. [DOI:10.1099/0022-1317-51-2-98]
14. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among Pneumococcal serotypes. Lancet Infect Dis. 2005;5(2):39-83. [DOI:10.1016/S1473-3099(05)70083-9]
15. Standish AJ, Salim AA, Zhang H, Capon RJ, Morona R. Chemical Inhibition of Bacterial Protein Tyrosine Phosphatase Suppresses Capsule Production. PLoS ONE. 2012;7(5):1-3. [DOI:10.1371/journal.pone.0036312]
16. Mäkinen KK, Bennett CA, Hujoel PP, Isokangas PJ, Isotupa KP, Pape HR Jr Et al. Xylitol chewing gums and caries rates. a 40-month cohort study. J Dent Res (74). (74):1904-13. [DOI:10.1177/00220345950740121501]
17. Kontiokari T, Uhari M, Koskela M. Effect of xylitol on growth of nasopharyngeal bacteria in vitro. Antimicrob Agents Chemother. 1995 (39):1820-3. [DOI:10.1128/AAC.39.8.1820]
18. Kontiokari T, Uhari M, Koskela M. Antiadhesive effects of xylitol on otopathogenic bacteria. J Antimicrob Chemother. 1998 (41):563-5. [DOI:10.1093/jac/41.5.563]
19. Tapiainen T, Kontiokari T, Sammalkivi L, Ikäheimo I, Koskela M, Uhari M. Effect of xylitol on growth of Streptococcus pneumoniae in the presence of fructose and sorbitol. Antimicrob Agents Chemother. 2001 (45):166-9. [DOI:10.1128/AAC.45.1.166-169.2001]
20. Kurola P, Tapiainen T, Kaijalainen T, Uhari M, Saukkor iipi A. Xylitol and capsular gene expression in Streptococcus pneumoniae. Journal of Medical Microbiology. 2009; 58:1470-3. [DOI:10.1099/jmm.0.011700-0]
21. Russell H, Tharpe JA, Wells DE, White EH, Johnson JE. Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae. J Clin Microbiol. 1990; 28:2192-5. [DOI:10.1128/jcm.28.10.2191-2195.1990]
22. Sampson JS, Furlow Z, Whitney AM, Williams D, Facklam R, Carlone GM. Limited diversity of Streptococcus pneumoniae psaA among pneumococcal vaccine serotypes. Infect Immun. 1997;65(5): 1967-71. [DOI:10.1128/iai.65.5.1967-1971.1997]
23. Berry A, Paton JC. Sequence heterogeneity of PasA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun. 1996; 64:5255-62. [DOI:10.1128/iai.64.12.5255-5262.1996]
24. Morrison KE, Lake D, Crook J, Carlone GM, Ades E, Facklam R, et al. Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis. J Clin Microbiol. 2000;38(1): 434-7. [DOI:10.1128/JCM.38.1.434-437.2000]
25. Ataee RA, Mehrabi-Tavana A, and Esmaili D. Serotyping Distribution of Invasive Pneumococcal Disease (IPD) in Iranian patients. J Pure Appl Microbiol. 2012; 6(1): 155-160.
26. Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J. 2013;15(10):e8053. [DOI:10.5812/ircmj.8053]
27. Tavana AM, Ataee R, Gerami M, Gooya M, Karami A, Ranjbar R, et al. A study investigating the Streptococcus Pneumoniae pattern among Iranian patients. Archives of Pharmacy Practice. 2012;3(2):122. [DOI:10.4103/2045-080X.112808]
28. Mohsenpoor M, MehrabiTavana A, Ataee R A, Ranjbar R, Mirnejad R. Isolation and Identification of Streptococcus pneumoniae from Admitted Patients in Tehran Hospitals in during 2013-2015. Iran J Med Microbiol. 2017; 11(2):09-16.
29. Asgari A, Ataee RA, Ghorbanalizadegan M, MehrabiTavana A . Diagnosis of Streptococcus pneumoniae based on cpsB , cpsD and psaA Genes. J Mazandaran Univ Med Sci. 2018;28(161)121-126.
30. Kanık Yüksek S, Gülhan B, Tezer H, Özkaya Parlakay A,Uzun Kenan B, Sayed Oskovi H,et al. Invasive pneumococcal disease in two non-vaccinated pediatric cases: pleural empyema and bacteremia. Mikrobiyol Bul. 2015;49(3):446-53. [DOI:10.5578/mb.9742]
31. Hanage WP, Fraser C, Tang J, Connor TR, Corander J. Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus. Science. 2009; 324;1454-7. [DOI:10.1126/science.1171908]
32. Asgari A, Ataee RA, Ghorbanalizadegan M, MehrabiTavana A. Effect of Xylitol on the Growth and Survival of Streptococcus pneumoniae. Jundishapur J Microbiol. 2018;11(12)e69319.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc